Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer

BACKGROUND: Upfront surgery followed by systemic treatment is recommended to treat clinical stage I–IIA small cell lung cancer (SCLC), but data on the clinical outcomes are sparse. Thus, this study evaluated the stage migration and long-term prognosis of surgically treated clinical stage I–IIA SCLC....

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Hyeok Sang, Song, Jae Won, Park, Samina, Park, In Kyu, Kang, Chang Hyun, Kim, Young Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Thoracic and Cardiovascular Surgery 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733413/
https://www.ncbi.nlm.nih.gov/pubmed/36457158
http://dx.doi.org/10.5090/jcs.22.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733413/
https://www.ncbi.nlm.nih.gov/pubmed/36457158
http://dx.doi.org/10.5090/jcs.22.085

Ejemplares similares